prodchem
Aug 19, 2026
Chemical companies are facing increasing scrutiny over how corporate restructuring affects long-term environmental liabilities.
In 2026, one of the most pointed examples came from California Attorney General Rob Bonta, who accused DuPont and its spun-off companies of using a “corporate shell game” to move assets away from potential PFAS creditors. The allegation was included in California's Second Amended Complaint filed on August 6, 2026.
The case provides an important benchmark for understanding how regulators are increasingly examining spin-offs, asset transfers, insurance rights and liability allocation together rather than as separate corporate transactions.
Bonta's characterization refers to allegations that DuPont and related companies structured transactions in a way that moved valuable assets away from Chemours while leaving substantial PFAS liabilities with it.
California alleges that these transactions were designed to:
Shift liabilities
Move valuable assets
Reduce creditor recovery
Separate profitable businesses
Transfer insurance rights
Protect assets through corporate restructuring
These are allegations, not established findings of wrongdoing.
The DuPont case stands out because the allegations cover multiple stages of corporate restructuring.
California's complaint discusses the creation of Chemours, subsequent DuPont reorganizations, the 2021 PFAS MOU, the 2025 transfer of certain insurance rights, and the later separation of Qnity Electronics.
The state argues that these transactions collectively created a structure in which Chemours retained significant potential liabilities while other entities retained substantial assets.
One of the most significant allegations concerns PFAS-related insurance rights.
California alleges that Chemours transferred 100% of certain PFAS insurance rights to Corteva and New DuPont in 2025 in exchange for a lump-sum payment that the state says was worth less than half the estimated value of those proceeds.
Insurance therefore becomes more than a financial recovery mechanism.
It becomes part of the legal debate over where value was located when liabilities were allocated.
California also points to DuPont's separation of its Electronics business into Qnity Electronics.
The state alleges that New DuPont continued separating valuable businesses and assets while historical PFAS liabilities remained elsewhere in the corporate structure.
Qnity's inclusion demonstrates why modern spin-offs can attract scrutiny when the parent company has substantial legacy environmental exposure.
The allegations directly challenge whether restructuring transactions were used improperly to limit liability exposure.
The case highlights the regulatory importance of where valuable assets are located after a corporate separation.
The transfer of potential PFAS insurance proceeds creates another important layer of scrutiny.
The Qnity separation demonstrates how newly independent companies can become relevant to legacy-liability disputes.
The broader dispute questions whether contractual arrangements can effectively concentrate liabilities in an entity with fewer assets.
The significance extends beyond DuPont.
Chemical companies frequently use:
Spin-offs
Divestitures
Mergers
Internal reorganizations
Asset transfers
Joint ventures
These transactions can improve strategic focus and shareholder value.
But when significant environmental liabilities exist, regulators may increasingly examine whether the restructuring also affects the ability of creditors or governments to recover damages.
DuPont is simultaneously pursuing a very different strategy in New Jersey.
Chemours, DuPont and Corteva agreed to an $875 million settlement over 25 years, resolving specified environmental and PFAS claims in the state. DuPont's agreed share is 35.5%.
This creates an interesting contrast:
New Jersey → Settlement and liability resolution
California → Challenge to corporate restructuring and asset transfers
The difference demonstrates how the same historical PFAS exposure can produce very different legal strategies across jurisdictions.
The California case could encourage greater scrutiny of future corporate reorganizations involving companies with legacy liabilities.
Boards and management teams may need to consider:
Asset valuation
Solvency
Liability allocation
Insurance ownership
Indemnification
Creditor rights
Timing of spin-offs
Post-separation asset sales
The legal question may increasingly become not simply “Was the transaction permitted?”, but also “Did the transaction leave creditors with meaningful access to assets?”
Investors should monitor:
Whether California's fraudulent-transfer theories survive procedural and substantive challenges.
Whether other states adopt similar approaches.
Whether courts restrict transfers involving assets associated with Old DuPont.
How PFAS insurance rights are ultimately allocated.
Whether future spin-offs attract additional regulatory scrutiny.
Bonta's “corporate shell game” characterization is notable because it frames corporate restructuring as a potential liability-management issue, rather than simply a strategic or financial transaction.
The California complaint remains an allegation, and the defendants will have the opportunity to contest the claims.
Nevertheless, the case provides an important 2026 benchmark for the chemical sector.
For investors, the lesson is to look beyond the balance sheet of a single company and examine where assets, liabilities, insurance rights and indemnities sit across the entire corporate structure.
For chemical companies, the broader message is clear:
Corporate restructuring may create new companies, but regulators are increasingly examining whether the underlying economic responsibility moved with the assets—or stayed behind with the liabilities.
California AG Rob Bonta described the alleged DuPont restructuring as a “corporate shell game.”
California alleges that DuPont-related transactions moved valuable assets away from potential PFAS creditors.
The allegations involve Chemours, New DuPont, Corteva and Qnity.
PFAS-related insurance rights are a major part of the dispute.
The Qnity spin-off adds another dimension to the corporate-restructuring allegations.
The claims remain allegations and have not been established as wrongdoing.
The case could increase scrutiny of future chemical-company spin-offs and asset transfers.
Investors should examine corporate structures, indemnities, insurance rights and legacy liabilities together.
Featured Product
Found this useful?
Continue Reading
India's growing chemical investment zones are strengthening domestic manufacturing capacity while supporting the country's ambition to become a preferred global destination for chemical production, exports and supply-chain diversification.
California Attorney General Rob Bonta is seeking to restrict New DuPont and Qnity from moving or using certain proceeds from former Old DuPont assets, highlighting growing scrutiny of chemical-company restructuring amid PFAS litigation.
India's three operating PCPIRs have grown into a substantial chemical manufacturing platform, with 2,246 functional units, ₹3.49 lakh crore in cumulative investment and 3.7 lakh jobs. Comparing the model with global chemical investment corridors shows where India's cluster strategy is already competitive and where infrastructure, integration and execution still matter.
